Organon & Co. Files 8-K on Director/Officer Changes

Ticker: OGN · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1821825

Organon & CO. 8-K Filing Summary
FieldDetail
CompanyOrganon & CO. (OGN)
Form Type8-K
Filed DateJun 12, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes

TL;DR

Organon leadership shakeup and votes filed.

AI Summary

Organon & Co. filed an 8-K on June 12, 2025, reporting on events that occurred on June 10, 2025. The filing covers the departure and election of directors, appointment of officers, and compensatory arrangements for certain officers. It also includes information on matters submitted to a vote of security holders and financial statements with exhibits.

Why It Matters

This filing provides crucial updates on the company's leadership and governance structure, which can impact strategic direction and investor confidence.

Risk Assessment

Risk Level: low — The filing is routine and reports on corporate governance matters without immediate financial implications.

Key Players & Entities

FAQ

What specific director or officer positions were affected by the changes reported in this 8-K?

The filing indicates changes related to the 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers', but the specific names and positions are not detailed in the provided excerpt.

Were there any significant votes by security holders mentioned in this filing?

Yes, the filing explicitly lists 'Submission of Matters to a Vote of Security Holders' as an item reported.

What is the primary business of Organon & Co. according to the filing?

Organon & Co. is in the 'PHARMACEUTICAL PREPARATIONS' industry, SIC code 2834.

Where is Organon & Co. headquartered?

Organon & Co. is headquartered at 30 Hudson Street, Floor 33, Jersey City, NJ 07302.

What is the SEC file number for this Organon & Co. 8-K filing?

The SEC file number for this filing is 001-40235.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Organon & Co. (OGN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing